Ep17: Sabrina Martucci Johnson (DARÉ Bioscience) – Paving the Future of Women’s Healthcare

Women’s Reproductive Health Innovation does not make headlines. WHY NOT? The global market for contraception was over $19 billion in 2015. IT’S COMPLICATED. Sabrina Martucci Johnson, CEO & Founder of DARÉ Bioscience, pulls back the cover and explains why and what her healthcare company is doing about it. Hint: Perhaps it’s because contraception is believed to be a 3rd world problem. Or perhaps there’s not enough women with investment authority at VC funds.

Sabrina Martucci Johnson is a life sciences executive with a record of achievement in capital formation, business development, and commercial leadership. Sabrina’s unique background spans finance, global marketing, product development and bench research. Sabrina is committed to advancing innovations in women’s health. In 2015 she founded DARÉ Bioscience to bring novel technologies that clearly address unmet needs to the clinic so that the latest concepts in women’s health make it to market.

Leave a Reply

Your email address will not be published. Required fields are marked *